Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S269000, C514S231500, C544S182000, C544S317000, C544S111000
Reexamination Certificate
active
06906068
ABSTRACT:
The invention relates to substituted polycyclic aryl and heteroaryl pyrimidinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
REFERENCES:
patent: 4489096 (1984-12-01), Terao et al.
patent: 4851413 (1989-07-01), Terao et al.
patent: 4992469 (1991-02-01), Ozawa et al.
patent: 5008267 (1991-04-01), Katakami et al.
patent: 5304658 (1994-04-01), Terao et al.
patent: 5441960 (1995-08-01), Bernstein et al.
patent: 5656645 (1997-08-01), Tamura et al.
patent: 5658930 (1997-08-01), Tamura et al.
patent: 5668289 (1997-09-01), Sanderson et al.
patent: 5741819 (1998-04-01), Illig et al.
patent: 5792779 (1998-08-01), Sanderson et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5866573 (1999-02-01), Sanderson et al.
patent: 5869487 (1999-02-01), Coburn et al.
patent: 5872138 (1999-02-01), Naylor-Olsen et al.
patent: 6011158 (2000-01-01), Tamura et al.
patent: 6037356 (2000-03-01), Lu et al.
patent: 6180627 (2001-01-01), Blagg et al.
patent: 198 51 421 (2000-05-01), None
patent: 0 354 495 (1990-02-01), None
patent: WO 98/09987 (1998-03-01), None
patent: WO 99/48892 (1998-09-01), None
patent: WO 99/43660 (1999-09-01), None
Rauch et al., Ann. Intern. Med. 134(3): 224-238, 2001.
Van Aken et al., clin. Appl. Thromb. Hemost., 7(3): 195-204, 2001.
Coburn, C.A., “Small-molecule direct thrombine inhibitors 1997-2000.” Expert Opinions on Therapeutic Patents, 2001, 721-738, vol. 11, No. 5.
XP-002182132—Darvas, et al., “Investigation of the Common Mechanism of Action of Antibacterial Compounds Containing .gamma.-pyridone-.beta.-carboxylic acid Structure by Principal Component.” Arzneim.-Forsch., 1979, pp. 1334-1339, vol. 29, 9.
XP-002172033—Kohama, et al., “Preparation of Piperidinyloxyacetylaminobenzoylalanine Derivatives and Analogs as Atithrombotics.” JP 07,233,148.
XP-002187583—Moerner, Hoppe-Seyler's Z. Physiol. Chem., 69, 1910; 357.
Patel, et al., “Directed Aminomethylation of 3-Hydroxy-3(1H)-pyridinones and 3-hycroxy-4(1H)-pryidinones: Synthesis of iso-Deferiprone.” Tetrahedron, 1996, pp. 1835-1840, vol. 52, No. 5.
XP-002182410—Trecourt, et al., “First Synthesis of (+−)-harzianopyridone by Metalation of Polysubstituted O-pyridylcarbamates.” J. Heterocycl. Chem., 1995, pp. 1117-1114, vol. 32, No. 4.
Tulinsky, et al., “Novel Asymmetric Synthesis of Atropisomeric 6-Aryl Pyrazinones via an Unusual Chirality Transfer Process.” J. Org. Chem., 1999, pp. 93-100, vol. 64, No. 1.
Hamme, II Ashton T.
Jones Darin E.
Neumann William L.
South Michael S.
Balasubramanian Venkataraman
Pharmacia Corporation
LandOfFree
Substituted polycyclic aryl and heteroaryl 1,2,4 -... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted polycyclic aryl and heteroaryl 1,2,4 -..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted polycyclic aryl and heteroaryl 1,2,4 -... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3460848